Pharmacologic effects of naldemedine, a peripherally acting μ‐opioid receptor antagonist, in in vitro and in vivo models of opioid‐induced constipation

por Kanemasa, Toshiyuki, Koike, Katsumi, Arai, Tohko, Ono, Hiroko, Horita, Narumi, Chiba, Hiroki, Nakamura, Atsushi, Morioka, Yasuhide, Kihara, Tsuyoshi, Hasegawa, Minoru
Publicado 2019

Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-methylpyrrolidine...

por Kobayashi, Naotake, Sato, Norihito, Fujimura, Yuko, Kihara, Tsuyoshi, Sugita, Katsuji, Takahashi, Kouji, Koike, Katsumi, Sugawara, Tamio, Tada, Yukio, Nakai, Hiroshi, Yoshikawa, Takayoshi
Publicado 2018

Correction to Discovery of the Orally Effective Thyrotropin-Releasing Hormone Mimetic: 1-{N-[(4S,5S)-(5-Methyl-2-oxooxazolidine-4-yl)carbonyl]-3-(thiazol-4-yl)-l-alanyl}-(2R)-2-met...

por Kobayashi, Naotake, Sato, Norihito, Fujimura, Yuko, Kihara, Tsuyoshi, Sugita, Katsuji, Takahashi, Kouji, Koike, Katsumi, Sugawara, Tamio, Tada, Yukio, Nakai, Hiroshi, Yoshikawa, Takayoshi
Publicado 2019